Correlation Between X4 Pharmaceuticals and Bioatla

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Bioatla, you can compare the effects of market volatilities on X4 Pharmaceuticals and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Bioatla.

Diversification Opportunities for X4 Pharmaceuticals and Bioatla

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between XFOR and Bioatla is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Bioatla go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Bioatla

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Bioatla. But the stock apears to be less risky and, when comparing its historical volatility, X4 Pharmaceuticals is 1.0 times less risky than Bioatla. The stock trades about -0.02 of its potential returns per unit of risk. The Bioatla is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  364.00  in Bioatla on August 26, 2024 and sell it today you would lose (207.00) from holding Bioatla or give up 56.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Bioatla

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

X4 Pharmaceuticals and Bioatla Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Bioatla

The main advantage of trading using opposite X4 Pharmaceuticals and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.
The idea behind X4 Pharmaceuticals and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance